| Issue Date | Title | Author(s) |
| 2022-02 | Absence of correlation between ABO Rh(D) blood group and neutralizing antibody titers in SARS-CoV-2 convalescent plasma donors. | Hirani, R; Hoad, V; Gosbell, IB; Irving, DO |
| 2021-01 | Aggregates in blood filter chambers used from the plasma donations of anti-D donors: evaluation for monoclonal antibody discovery using phage display. | McGowan, EC; Flower, RL; Jones, ML; Irving, DO; Barnard, RT; Hyland, CA; Mahler, SM; Bui, XT |
| 2021-12-01 | An Ovine Model of Hemorrhagic Shock and Resuscitation, to Assess Recovery of Tissue Oxygen Delivery and Oxygen Debt, and Inform Patient Blood Management. | Dyer, WB; Tung, J-P; Li Bassi, G; Wildi, K; Jung, J-S; Colombo, SM; Rozencwajg, S; Simonova, G; Chiaretti, S; Temple, FT; Ainola, C; Shuker, T; Palmieri, C; Shander, A; Suen, JY; Irving, DO; Fraser, JF |
| 2020 | Comparison of group O Rh(D)− red blood cell use in pregnant women across hospitals of various sizes and obstetric capabilities prior to the introduction of patient blood management guidelines | Patterson, JA; Hirani, R; Irving, DO; Nicholl, MC; Ford, JB |
| 2019-01-01 | Completeness and accuracy of self-reported history of blood donation: results from a cohort of older adults in Australia | Karki, S; Davison, TE; Thijsen, A; Gemelli, CN; Irving, DO; Wright, ST |
| 2016-08-01 | Determining the effect of vein visualization technology on donation success, vasovagal symptoms, anxiety and intention to re-donate in whole blood donors aged 18–30 years: A randomized controlled trial | Waller, D; Mondy, P; Brama, T; Fisher, J; King, A; Malkov, K; Wall-Smith, D; Ryan, L; Irving, DO |
| 2021-10-21 | Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells. | Bishop, DC; Clancy, LE; Simms, R; Burgess, J; Mathew, G; Moezzi, L; Street, JA; Sutrave, G; Atkins, E; McGuire, HM; Gloss, BS; Lee, K; Jiang, W; Maddock, K; McCaughan, G; Avdic, S; Antonenas, V; O'Brien, TA; Shaw, PJ; Irving, DO; Gottlieb, DJ; Blyth, E; Micklethwaite, KP |
| 2016-09-01 | Hepcidin is a better predictor of iron stores in premenopausal women than blood loss or dietary intake | Lim, KHC; Booth, AO; Nowson, CA; Szymlek-Gay, EA; Irving, DO; Riddell, LJ |
| 2016-10-01 | Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy | Dyer, WB; Tan, JCG; Day, T; Kiers, L; Kiernan, MC; Yiannikas, C; Reddel, S; Ng, K; Mondy, P; Dennington, PM; Dean, MM; Trist, HM; dos Remedios, C; Hogarth, PM; Vucic, S; Irving, DO |
| 2021-03 | Long-term return and donation pattern of those who begin donating at different ages: A retrospective cohort analysis of blood donors in Australia. | Priyono, A; Masser, BM; Dyda, A; Davison, TE; Irving, DO; Karki, S |
| 2019-10 | Mortality and hospital readmissions in the first year of life after intra‐uterine and neonatal blood product transfusions: A population data linkage study | Randall, DA; Bowen, JR; Patterson, JA; Irving, DO; Hirani, R; Ford, JB |
| 2022-04-04 | Recovery of organ-specific tissue oxygen delivery at restrictive transfusion thresholds after fluid treatment in ovine haemorrhagic shock | Dyer, WB; Simonova, G; Chiaretti, S; Bouquet, M; Wellburn, R; Heinsar, S; Ainola, C; Wildi, K; Sato, K; Livingstone, S; Suen, JY; Irving, DO; Tung, J-P; li Bassi, G; Fraser, JF |
| 2023-05 | Regular high-frequency whole blood donation and risk of cardiovascular disease in middle-aged and older blood donors in Australia. | Karki, S; Bell, KJL; Hayen, A; Liu, B; Cust, AE; Olynyk, JK; Irving, DO |
| 2021-02-04 | SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays | Walker, GJ; Naing, Z; Stella, AO; Yeang, M; Caguicla, J; Ramachandran, V; Isaacs, SR; Agapiou, D; Bull, RA; Stelzer-Braid, S; Daly, J; Gosbell, IB; Hoad, VC; Irving, DO; Pink, JM; Turville, S; Kelleher, AD; Rawlinson, WD |
| 2021-07-06 | SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants. | Tea, F; Ospina Stella, A; Aggarwal, A; Ross Darley, D; Pilli, D; Vitale, D; Merheb, V; Lee, FXZ; Cunningham, P; Walker, GJ; Fichter, C; Brown, DA; Rawlinson, WD; Isaacs, SR; Mathivanan, V; Hoffmann, M; Pöhlman, S; Mazigi, O; Christ, D; Dwyer, DE; Rockett, RJ; Sintchenko, V; Hoad, VC; Irving, DO; Dore, GJ; Gosbell, IB; Kelleher, AD; Matthews, GV; Brilot, F; Turville, SG |
| 2022 | Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020. | Machalek, DA; Vette, KM; Downes, M; Carlin, JB; Nicholson, S; Hirani, R; Irving, DO; Gosbell, IB; Gidding, HF; Shilling, H; Aung, E; Macartney, K; Kaldor, JM; Aboelhadid, SM |
| 2021-02-03 | Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020 | Gidding, HF; Machalek, DA; Hendry, AJ; Quinn, HE; Vette, K; Beard, FH; Shilling, HS; Hirani, R; Gosbell, IB; Irving, DO; Hueston, L; Downes, M; Carlin, JB; O'Sullivan, MV; Dwyer, DE; Kaldor, JM; Macartney, K |
| 2022-03 | Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey. | Vette, KM; Machalek, DA; Gidding, HF; Nicholson, S; O'Sullivan, MVN; Carlin, JB; Downes, M; Armstrong, L; Beard, FH; Dwyer, DE; Gibb, R; Gosbell, IB; Hendry, AJ; Higgins, G; Hirani, R; Hueston, L; Irving, DO; Quinn, HE; Shilling, H; Smith, D; Kaldor, JM; Macartney, K |
| 2021-10-07 | Visits to general practitioners after iron-related deferrals from blood donation in middle-aged and older Australian blood donors. | Karki, S; Davison, TE; Liu, B; Bell, K; Olynyk, JK; Hayen, A; Irving, DO |
| 2021-10 | Willingness of blood donors in Australia to provide additional data and blood sample for health research. | Karki, S; Gemelli, CN; Davison, TE; Masser, BM; Marks, DC; Bell, K; Liu, B; Hayen, A; van den Hurk, K; Irving, DO |
